4//SEC Filing
BIOENVISION INC 4
Accession 0000950142-04-004512
CIK 0001028205operating
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 11:47 AM ET
Size
34.0 KB
Accession
0000950142-04-004512
Insider Transaction Report
Form 4
BIOENVISION INCBIVN
SFM PARTICIPATION LP
10% OwnerOther
Transactions
- Sale
Common Stock
2004-12-21$8.53/sh−52$444→ 390,386 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value ("Common Stock")
2004-12-21$8.40/sh−21,172$177,845→ 411,037 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.41/sh−316$2,658→ 410,721 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.48/sh−35$297→ 395,876 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.42/sh−4,208$35,431→ 406,513 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.43/sh−209$1,762→ 406,304 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.44/sh−1,160$9,790→ 405,144 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.46/sh−1,621$13,714→ 397,059 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.47/sh−1,148$9,724→ 395,911 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.52/sh−18$153→ 390,438 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.45/sh−6,464$54,621→ 398,680 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.50/sh−3,655$31,068→ 392,186 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.51/sh−1,730$14,722→ 390,456 total(indirect: See Footnotes)
PERSEUS BIOTECH FUND PARTNERS LLC
10% OwnerOther
Transactions
- Sale
Common Stock
2004-12-21$8.41/sh−316$2,658→ 410,721 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.52/sh−18$153→ 390,438 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.43/sh−209$1,762→ 406,304 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.46/sh−1,621$13,714→ 397,059 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.50/sh−3,655$31,068→ 392,186 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.42/sh−4,208$35,431→ 406,513 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.48/sh−35$297→ 395,876 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value ("Common Stock")
2004-12-21$8.40/sh−21,172$177,845→ 411,037 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.47/sh−1,148$9,724→ 395,911 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.44/sh−1,160$9,790→ 405,144 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.45/sh−6,464$54,621→ 398,680 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.51/sh−1,730$14,722→ 390,456 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.53/sh−52$444→ 390,386 total(indirect: See Footnotes)
PERSEUS SOROS PARTNERS LLC
10% OwnerOther
Transactions
- Sale
Common Stock
2004-12-21$8.44/sh−1,160$9,790→ 405,144 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.43/sh−209$1,762→ 406,304 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.50/sh−3,655$31,068→ 392,186 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.41/sh−316$2,658→ 410,721 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.48/sh−35$297→ 395,876 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.46/sh−1,621$13,714→ 397,059 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.53/sh−52$444→ 390,386 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value ("Common Stock")
2004-12-21$8.40/sh−21,172$177,845→ 411,037 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.52/sh−18$153→ 390,438 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.42/sh−4,208$35,431→ 406,513 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.47/sh−1,148$9,724→ 395,911 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.45/sh−6,464$54,621→ 398,680 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.51/sh−1,730$14,722→ 390,456 total(indirect: See Footnotes)
SFM AH LLC
10% OwnerOther
Transactions
- Sale
Common Stock
2004-12-21$8.42/sh−4,208$35,431→ 406,513 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.50/sh−3,655$31,068→ 392,186 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.52/sh−18$153→ 390,438 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.41/sh−316$2,658→ 410,721 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.45/sh−6,464$54,621→ 398,680 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.44/sh−1,160$9,790→ 405,144 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.51/sh−1,730$14,722→ 390,456 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.53/sh−52$444→ 390,386 total(indirect: See Footnotes) - Sale
Common Stock, $0.001 par value ("Common Stock")
2004-12-21$8.40/sh−21,172$177,845→ 411,037 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.48/sh−35$297→ 395,876 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.43/sh−209$1,762→ 406,304 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.46/sh−1,621$13,714→ 397,059 total(indirect: See Footnotes) - Sale
Common Stock
2004-12-21$8.47/sh−1,148$9,724→ 395,911 total(indirect: See Footnotes)
Footnotes (4)
- [F1]These shares sold were held by Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners").
- [F2]These securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP, a Delaware limited partnership ("Perseus-Soros") and Perseus-Soros Partners. Perseus-Soros Partners is the general partner of Perseus-Soros. Perseus BioTech Fund Partners, LLC, a Delaware limited liability company ("Perseus Partners") and SFM Participation, L.P., a Delaware limited partnership ("SFM Participation"), are the managing members of Perseus-Soros Partners. Perseus-Soros Partners, Perseus Partners, SFM Participation and SFM AH LLC may be deemed to beneficially own the 375,044 shares directly beneficially owned by Perseus-Soros after the transactions reported herein and in the other Form 4's filed by the reporting persons on December 23, 2004.
- [F3]SFM AH LLC, a Delaware limited liability company ("SFM AH"), is the general partner of SFM Participation.
- [F4]Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), Perseus-Soros Partners, Perseus Partners, SFM Participation and SFM AH are deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros or Perseus-Soros Partners only to the extent of the greater of its respective direct or indirect interest in the profits or capital account of Perseus-Soros or Perseus-Soros Partners. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that Perseus-Soros Partners, Perseus Partners, SFM Participation or SFM AH is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros or Perseus-Soros Partners in excess of such amount.
Documents
Issuer
BIOENVISION INC
CIK 0001028205
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001028205
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 11:47 AM ET
- Size
- 34.0 KB